These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of ultrafiltration on peritoneal dialysis drug clearances. Lau AH; Chow-Tung E; Assadi FK; Fornell L; John E Pharmacology; 1985; 31(5):284-8. PubMed ID: 4070353 [TBL] [Abstract][Full Text] [Related]
4. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Kuhlmann MK Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819 [TBL] [Abstract][Full Text] [Related]
5. Drugs in renal failure: dosing guidelines for frequently used drugs in end-stage renal disease and dialysis patients. Seyffart G Blood Purif; 1985; 3(1-3):140-68. PubMed ID: 4096834 [No Abstract] [Full Text] [Related]
6. Factors affecting hemodialysis and peritoneal dialysis efficiency. Ronco C; Clark W Semin Dial; 2001; 14(4):257-62. PubMed ID: 11489199 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. II. On hemodialysis. van der Vijgh WJ Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):255-9. PubMed ID: 881277 [TBL] [Abstract][Full Text] [Related]
9. Radionuclide method for evaluating the performance of hemodialysis in vivo. Bihl GR; Bird NJ; Peters C; Bradley JR; Peters AM Kidney Int; 2005 Feb; 67(2):721-31. PubMed ID: 15673322 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics in renal disease. Levy G Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113 [TBL] [Abstract][Full Text] [Related]
11. [Effect of hemodialysis on digoxin pharmacokinetics in heart failure in patients with chronic kidney failure]. Kholodov LE; Glezer MG; Grigor'eva EA; Ksenzenko BL; Solianik GI Kardiologiia; 1984 Jun; 24(6):94-7. PubMed ID: 6748501 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis. Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079 [TBL] [Abstract][Full Text] [Related]
13. The biotransformation of drugs in renal failure. Reidenberg MM Am J Med; 1977 Apr; 62(4):482-5. PubMed ID: 851117 [TBL] [Abstract][Full Text] [Related]
14. [Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis]. Grzegorzewska A; Antoniewicz K; Kuźniak J; Zawadzka E Przegl Lek; 1990; 47(10):686-90. PubMed ID: 2089444 [TBL] [Abstract][Full Text] [Related]
15. [Peritoneal dialysis in the aged]. Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386 [TBL] [Abstract][Full Text] [Related]
16. Solute and Water Transport in Peritoneal Dialysis: A Case-Based Primer. Khanna R Am J Kidney Dis; 2017 Mar; 69(3):461-472. PubMed ID: 28111028 [TBL] [Abstract][Full Text] [Related]
17. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Douma CE; de Waart DR; Struijk DG; Krediet RT Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660 [TBL] [Abstract][Full Text] [Related]
18. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis. Churchwell MD; Pasko DA; Smoyer WE; Mueller BA Nephrol Dial Transplant; 2009 Jan; 24(1):231-8. PubMed ID: 18723569 [TBL] [Abstract][Full Text] [Related]
19. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis. Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690 [TBL] [Abstract][Full Text] [Related]